ClearPoint Neuro: Momentum Building Across The Business
ClearPoint Neuro, Inc. Q3 2026 Earnings Call Summary
Stifel Maintains Buy on ClearPoint Neuro, Lowers Price Target to $18
ClearPoint Neuro (CLPT) Q3 2026 Earnings Call Transcript
What ClearPoint Neuro (CLPT) Said on Its Q3 Earnings Call
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates
ClearPoint Neuro (NASDAQ:CLPT) Falls 25% as Q3 Revenue Miss Overshadows EPS Beat
ClearPoint Neuro, Inc. (CLPT) Q3 2026 Earnings Call Transcript
ClearPoint Neuro Reports Third Quarter 2026 Results
ClearPoint Neuro Q3 2026 Earnings Call Transcript
ClearPoint Neuro Narrows FY2026 Sales Guidance from $48.000M-$52.000M to $48.000M-$50.000M vs $49.000M Est
ClearPoint Neuro Q3 EPS $(0.24) Beats $(0.32) Estimate, Sales $12.075M Miss $12.300M Estimate
ClearPoint Neuro to Announce Third Quarter 2026 Results October 28, 2026
ClearPoint Neuro Shares Fall 24% Following uniQure AMT-130 Trial Update
ClearPoint Neuro (CLPT) Stock Sees Fair Value Cut As Analysts Factor In Heavier Investment
ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript
ClearPoint Neuro: Regulatory Momentum Strengthens The Long-Term Investment Case
ClearPoint Neuro, Inc. Q2 2026 Earnings Call Summary
ClearPoint Neuro, Inc. (CLPT) Q2 2026 Earnings Call Transcript
ClearPoint Neuro (CLPT) Reports Q2 Earnings: What Key Metrics Have to Say
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.